RecruitingNCT05958940
Bright-light therapy timing and setting for depressive episodes and bipolarity
About this title
Read the official source — NCT05958940Device studyAges 18–65NetherlandsDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Eindhoven and 1 more locationSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 8, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 231
- Sponsor
- Universiteit Leiden
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- DEVICE, PROCEDURE
- Study phase
- Not clearly listed
- Locations
- Netherlands
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05958940
- Official title
Show the full official title
BioClock: Optimization, Working Mechanisms and Response Predictors of Bright Light Therapy for Depressive Disorders - a Multicentre Randomized Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Eindhoven · Leiden
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Universiteit Leiden.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to explore more studies?
Explore studiesRelated studies
Sodium oxybate as a potential new treatment for catatonia in patients with depression, Bipolarity or a psychotic disorder
Sodium oxybate as a potential new treatment for catatonia in patients with depression, Bipolarity or a psychotic disorder, a randomized controlled trial. The Laborit study.
